Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Opioid-Related Disorders × Lymphoid × Clear all

Phase

Status

Completed 4 Withdrawn 2 Unknown 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 294 Precursor Cell Lymphoblastic Leukemia-Lymphoma 285 Lymphoma, Non-Hodgkin 211 Lymphoma, Large B-Cell, Diffuse 195 Lymphoma, Follicular 180 Leukemia, Lymphocytic, Chronic, B-Cell 154 Lymphoma, B-Cell 136 Recurrence 114 Lymphoma, Mantle-Cell 107 Leukemia 101 Leukemia, Myeloid, Acute 100 Burkitt Lymphoma 99 Hodgkin Disease 89 Multiple Myeloma 85 Lymphoma, B-Cell, Marginal Zone 81 Neoplasms 77 Hematologic Neoplasms 60 Myelodysplastic Syndromes 59 Lymphoma, T-Cell, Peripheral 57 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 54 Lymphoma, T-Cell 46 Waldenstrom Macroglobulinemia 42 Lymphoma, T-Cell, Cutaneous 41 Leukemia, Biphenotypic, Acute 33 Mycosis Fungoides 31 Leukemia, B-Cell 27 Lymphoproliferative Disorders 26 Breast Neoplasms 26 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25 Myeloproliferative Disorders 23

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06651177 2026-03-05

TAB

University of Cincinnati

Phase 2 Recruiting

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡